Cargando…
Radiotherapy concurrently with weekly cisplatin, followed by adjuvant chemotherapy, for N2–3 nasopharyngeal cancer: a multicenter trial of the Forum for Nuclear Cooperation in Asia
The purpose of this study was to evaluate the efficacy and toxicity of radiotherapy concurrently with weekly cisplatin, followed by adjuvant chemotherapy, for the treatment of N2–3 nasopharyngeal cancer (NPC) in Asian countries, especially regions of South and Southeast Asian countries where NPC is...
Autores principales: | Ohno, Tatsuya, Thinh, Dang Huy Quoc, Kato, Shingo, Devi, C.R. Beena, Tung, Ngo Thanh, Thephamongkhol, Kullathorn, Calaguas, Miriam Joy C., Zhou, Juying, Chansilpa, Yaowalak, Supriana, Nana, Erawati, Dyah, Banu, Parvin Akhter, Koo, Cho Chul, Kobayashi, Kunihiko, Nakano, Takashi, Tsujii, Hirohiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650741/ https://www.ncbi.nlm.nih.gov/pubmed/23192700 http://dx.doi.org/10.1093/jrr/rrs115 |
Ejemplares similares
-
Concurrent chemoradiotherapy for T3–4 and N0–1 nasopharyngeal cancer: Asian multicenter trial of the Forum for Nuclear Cooperation in Asia
por: Ohno, Tatsuya, et al.
Publicado: (2016) -
Multicentre dose audit for clinical trials of radiation therapy in Asia
por: Mizuno, Hideyuki, et al.
Publicado: (2017) -
Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients
por: Petsuksiri, Janjira, et al.
Publicado: (2011) -
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
por: Setakornnukul, Jiraporn, et al.
Publicado: (2018) -
Added survival benefit of whole brain radiotherapy in brain metastatic non-small cell lung cancer: Development and external validation of an individual prediction model
por: Trikhirhisthit, Kyrhatii, et al.
Publicado: (2022)